Doktor › Prof. Dr. Ethem TANKURT
Ana Sayfa  ›  Hekimlerimiz  ›  Prof. Dr. Ethem TANKURT
Prof. Dr. Ethem TANKURT

Uzmanlık Alanı
İç Hastalıkları
Gastroenteroloji

Akademik Unvanı
Profesör Doktor

Yabancı Dil
İngilizce

Eğitim - Çalıştığı Kurumlar
Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları (Uzm.)
Marmara Üniversitesi Tıp Fakültesi Gastroenteroloji (Uzm.)
Marmara Üniversitesi Tıp Fakültesi Doç. (1991)
9 Eylül Üniversitesi Tıp Fakültesi Prof. (1997)
European Board of Gastroenterology (2005)
American Gastroenterological Association (2007)

Dernekler 
EASL European Association for the Study of Liver
Türk Gastroenteroloji Derneği 
TASL Türk Karaciğer Araştırmaları Derneği
İç Hastalıkları Uzmanlık Derneği

Bilimsel Aktiviteler
Hopital Paul Brousse (Paris) Karaciğer Transplantasyonu üzerine çalışma, 1994

YAYINLAR
Yayın Kurulunda Olduğu Dergiler
Turkish Journal Of Gastroenterology
Türk Geriatri Dergisi
Gastroentero Hepatoloji Dergisi

Uluslararası  Dergilerde Yayınlanmış Çalışmaları
Inhibition of cholecystokinin induced gallbladder contraction by atropine and pirenzepine in man. B.Ç.Yeğen, E.Tankurt, N.Gürmen,Ş.Oktay, N.B.Ulusoy. Digestion 1990;45:176-180 
The effect of diltiazem on renal function in patients with liver cirrhosis. N.Tözün, K.Berkman, E.Tankurt, S.Aran, Y.Taga. International Journal of Clinical Pharmacology Therapy and Toxicology 1991;29(5):190-203
Cholecystokinin-induced contractions in the opossum gallbladder. N.B.Ulusoy, Ş.Oktay, B.Ç.Yeğen, E.Tankurt. Gastroenterology 1991;100:847
Influence of pirenzepine on gallbladder contraction in man induced by sham feeding or an intraduodenal meal. E.Tankurt, B.Ç.Yeğen, T.Biren, Ş.Oktay, N.B.Ulusoy. Digestion 1992;51:103-109
Endoscopic removal of swallowed endotracheal tubes from two patients: an unusual complication of coronary by-pass surgery.C.Kalaycı, E.Tankurt, N.Tözün, N.B.Ulusoy. Endoscopy 1994;26:364
Adverse allergic reaction to technettium-99m-Mebrofenine. B.Değirmenci, H.Durak, E.Ellidokuz, E.Tankurt. The Journal of Nuclear Medicine 1994;35:1569
Nasobiliary tube impaction during shock wave lithotripsy of common bile duct stone. E.Tankurt, H.Akbaylar, S.Bora, H.Gülay, İ.Şimşek, Ö.Gönen. Gastrointestinal Endoscopy  1995;41:84
Portal vein thrombosis associated with bladder carcinoma. E.Tankurt, A.Çömlekçi, H.Akbaylar, A.Esen, O.Dicle. American Journal of Gastroenterology 1995;90(3):521-522
Modulation of gallbladder contraction by pirenzepine in humans. B.Ç.Yeğen, T.Biren, F.Onat, E.Tankurt , N.Gürmen, Ş.Oktay, W.Y.Chey, N.B.Ulusoy. American Journal of Gastroenterology 1995;90(9):1489-1494
Severe long-lasting symptoms from doxycycline-induced esophageal injury. E.Tankurt, H.Akbaylar, Y.Yeniçerioğu,İ. Şimşek, Ö.Gönen. Endoscopy 1995;27(8):626
Cholecystokinin-induced gallbladder contraction and muscarinic blockade with pirenzepine in man.N.B.Ulusoy, Ş. Oktay, B.Ç. Yeğen, E. Tankurt ,  N. Gürmen. Digestive Disease and Sciences 1995;40(2):427
The prokinetic effect of domperidone in gallbladder, not upon dopaminergic receptors. E.Tankurt, Ş.Apaydın, E.Ellidokuz, E.İğici, H.Güven, İ.Şimşek, Ö.Gönen. Pharmacological Research 1996;33(3):153-156
Resolving FMF attacks with interferon alpha. E.Tankurt, M.Tunca, H.Akbaylar, Ö.Gönen. British Journal of Rheumatology 1996;35:11:1188
The efficacy of interferon alpha on colchicine-resistant FMF attacks. M.Tunca, E.Tankurt, H.Akbaylar, S.Akar, N.Hızlı, Ö.Gönen. British Journal of Rheumatology 1997;36:1005-1008
Increased serum nitrite and nitrate concentrations in chronic hepatitis. E.Tankurt, G.Kırkalı, M.Özcan. E.Ellidokuz. J Hepatol 1998;29:512-513
Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis. E.Tankurt, S.Biberoğlu, E.Ellidokuz, Z.Hekimsoy, H.Akpınar, A.Çömlekçi, A.Okan, Ö.Sağol. J Hepatol 1999;31:963-968
Endoscopic Sphincterotomy in the Management of Biliary Leakage after Partial Hepatectomy. A.Okan, E.Tankurt, H.Astarcıoğlu, C.Aydın, H.Akpınar, İ.Astarcıoğlu. Hepato-Gastroenterology 1999;46:790-791
Mirizzi syndrome: Diagnostic and surgical considerations on 24 cases. S.Karademir, H.Astarcıoğlu, S.Sökmen, K.Atilla, E.Tankurt, H.Akpınar, A.Çoker, I.Astarcıoğlu. Journal of HPB Surgery 2000;7:72-77
Serum Concentrarions of IGF-1 and IGFBP-3 in Patients with Chronic Hepatitis. A.Okan, A.Çömlekçi, H.Akpınar, İ.Okan, S.Yeşil, E.Tankurt, İ.Şimşek. Scan J Gastroenterol 2000;35:1212-1215
Risk factors for hepatocellular carcinoma in Turkey. Uzunalimoğlu Ö, Yurdaydın C, Çetinkaya H, Bozkaya H, Şahin T, Çolakoğlu S, Tankurt E, Özenirler S, Sarıoğlu M, Akkiz H, Tözün N, Değertekin H, Ökten A. Dig Dis Sci 2001; 46 (5):1022-1028
Effect of ursodeoxycholic acid on hepatic steatosis in rats. A.Okan, H.Astarcıoğlu, E.Tankurt, Ö.Sağol, E.Altekin, İ.Astarcıoğlu, Ö.Gönen. Dig Dis Sci 2002, 47:2389-2397
Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers:A case control study. A.Okan, E.Tankurt, B.Aslan, H.Akpınar, İ.Şimşek, Ö.Gönen. J Gastroenterol Hepatol 2003;18:18-25
The role of serum leptin levels in chronic hepatitis C with steatosis. E. Ellidokuz, A.Çömlekçi, H.Ellidokuz, H.Akpınar, Ç.Gökçe, E.Tankurt, Ö.Sağol, İ. Şimşek, Ö. Gönen. Hepatogastroenterology 2003 Dec;50 Supl 2.
Serum leptin levels in patients with cirrhosis and chronic hepatitis. A Çömlekçi, H. Akpınar, S. Yeşil, İ.Okan, E. Ellidokuz, A.Okan, G.Ersöz, E.Tankurt, Y. Batur. Scand Gastroenterol 2003 Jul;38(7):779-86
The effect of interferon alpha administration on acute attacks of familial mediterannean fever. M. Tunca, S.Akar, M.Soytürk, G.Kırkalı, H.Resmi, H.Akhunlar, Ö.Gönen, JR.Gallimore, PN Hawkins, E.Tankurt. Clin Exp Rheumatol 2004 Jul-Aug;22:37-40
Diagnostic usefulness of carbohydrate antigen-125 in cancerous and noncancerous peritoneal effusions. T Kemer, M. Örmen, F. Kuralay, M. Pehlivan, B. Ünsal, E.Tankurt. Tohoku J Exp Med 2005 Jan;205(1):11-18
Toxic hepatitis associated with paroxetine. O. Çolakoğlu, E. Tankurt, B. Ünsal, F. Ugur, A. Küpelioğlu, Z. Buyraç, Z. Akpınar. Int J Clin Pract 2005 Jul;59(7):861-2
Profilactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamuvidine after liver transplantation. S. Karademir, H. Astarcıoğlu, M. Akarsu, S. Özkardesler, D. Özzeybek, A. Sayıner, M. Akan, E. Tankurt, I. Astarcıoğlu. Transplt Proc 2006 Mar;38(2): 579-83
Pegylated Interferon Alfa-2b monotherapy and pegylated interferon Alfa-2b plus lamivudine combination therapy for patients with hepatits B virus E antigen-negative chronic hepatitis B. Kaymakoğlu S. , Oğuz D, Gür G, Gürel S, Tankurt E, Ersöz G, Kalaycı C, Ökten A. Antimicrob Agents Chemoter 2007 Aug;51(8):3020-2
YMDD Motif variants in inactive hepatits B carniers detected by Inno-Lipa HBV - DNA assay. Akarsu M, Sengönül A, Tankurt E, Sayıner A, Topalak Ö, Akpinar H, Abacıoğlu H. J Gastroenterol Hepatol 2006 Dec;21(12): 1783-8
Safety and tolerability of BRAVO capsule pH monitoring. Tankurt E, Tüzömay N, Sengül B, Kinik E, Açil B. Turk J Gastroenterol. 2011 Jun;22(3):352-3
Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis. Akinci B, Comlekci A, Tankurt E. Exp Clin Endocrinol Diabetes. 2009 Mar;117(3):142-5. Epub 2008 Jun 17
Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis. Yener S, Akarsu M, Demir T, Akinci B, Sagol O, Bayraktar F, Ozcan MA, Tankurt E, Yesil S. J Endocrinol Invest. 2007 Nov;30(10):810-9
Dr. Ethem Tankurt’un ayrıca ulusal dergilerde yayınlanmış 41 makalesi ve 8 kitap bölümü bulunmaktadır.